Connection

YANG O HUH to Humans

This is a "connection" page, showing publications YANG O HUH has written about Humans.
Connection Strength

0.194
  1. Chronic lymphocytic leukemia with plasmacytic differentiation. Ann Hematol. 2019 Oct; 98(10):2437-2438.
    View in: PubMed
    Score: 0.013
  2. Homogeneously staining region (hsr) on chromosome 11 is highly specific for KMT2A amplification in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Cancer Genet. 2019 10; 238:18-22.
    View in: PubMed
    Score: 0.013
  3. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations. Br J Haematol. 2018 05; 181(3):305.
    View in: PubMed
    Score: 0.012
  4. Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphoma in a patient treated with azathioprine for ulcerative colitis. Pathology. 2016 Aug; 48(5):513-5.
    View in: PubMed
    Score: 0.011
  5. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype. Cancer Genet. 2016 Jul-Aug; 209(7-8):313-20.
    View in: PubMed
    Score: 0.011
  6. A case of multiple myeloma mimics: extensive bone metastasis of hepatocellular carcinoma without liver mass. Blood. 2016 Jan 21; 127(3):368.
    View in: PubMed
    Score: 0.010
  7. B-Lymphoblastic Leukemia in Patients With Chronic Lymphocytic Leukemia: A Report of Four Cases. Am J Clin Pathol. 2015 Aug; 144(2):333-40.
    View in: PubMed
    Score: 0.010
  8. Chronic lymphocytic leukemia with t(14;19)(q32;q13) is characterized by atypical morphologic and immunophenotypic features and distinctive genetic features. Am J Clin Pathol. 2011 May; 135(5):686-96.
    View in: PubMed
    Score: 0.007
  9. T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: a clinicopathologic study of nine cases. Am J Clin Pathol. 2009 Mar; 131(3):347-56.
    View in: PubMed
    Score: 0.006
  10. Utility of the World Heath Organization classification criteria for the diagnosis of systemic mastocytosis in bone marrow. Mod Pathol. 2009 Jan; 22(1):50-7.
    View in: PubMed
    Score: 0.006
  11. MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis. Br J Haematol. 2008 Jul; 142(1):36-44.
    View in: PubMed
    Score: 0.006
  12. The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. Br J Haematol. 2007 Jan; 136(2):220-8.
    View in: PubMed
    Score: 0.006
  13. inv(16)(p13q22) in chronic myelogenous leukemia in blast phase: a clinicopathologic, cytogenetic, and molecular study of five cases. Am J Clin Pathol. 2005 Nov; 124(5):807-14.
    View in: PubMed
    Score: 0.005
  14. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARalpha transcripts and poorer prognosis. Am J Clin Pathol. 2004 Mar; 121(3):402-7.
    View in: PubMed
    Score: 0.005
  15. More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia. Leukemia. 2002 Nov; 16(11):2249-52.
    View in: PubMed
    Score: 0.004
  16. Discrepancies in the immunophenotype of lymphoma cells in samples obtained simultaneously from different anatomic sites. Am J Clin Pathol. 2002 Apr; 117(4):644-50.
    View in: PubMed
    Score: 0.004
  17. RE: Therapeutic plasma exchange: a paired comparison of Fresenius AS104 vs. COBE Spectra. J Clin Apher. 2002; 17(1):49.
    View in: PubMed
    Score: 0.004
  18. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease. Hematol Oncol Clin North Am. 2000 Dec; 14(6):1251-65.
    View in: PubMed
    Score: 0.004
  19. Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry. Leuk Lymphoma. 2000 Apr; 37(3-4):319-31.
    View in: PubMed
    Score: 0.003
  20. MYC protein expression is an important prognostic factor in acute myeloid leukemia. Leuk Lymphoma. 2019 01; 60(1):37-48.
    View in: PubMed
    Score: 0.003
  21. Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm. Am J Hematol. 2017 Jun; 92(6):520-528.
    View in: PubMed
    Score: 0.003
  22. The clinical significance of 8q24/MYC rearrangement in chronic lymphocytic leukemia. Mod Pathol. 2016 05; 29(5):444-51.
    View in: PubMed
    Score: 0.003
  23. Philadelphia-positive dimorphic blasts in mixed-phenotype acute leukemia with TET2 mutation. Am J Hematol. 2016 06; 91(6):647-8.
    View in: PubMed
    Score: 0.003
  24. Primary autoimmune myelofibrosis as etiology of pancytopenia mimicking myelodysplastic syndrome. Leuk Lymphoma. 2016; 57(3):731-4.
    View in: PubMed
    Score: 0.003
  25. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation. Cancer Genet. 2015 Nov; 208(11):571-4.
    View in: PubMed
    Score: 0.002
  26. Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. Blood. 2015 May 21; 125(21):3360-3.
    View in: PubMed
    Score: 0.002
  27. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol. 2015 Jan; 46(1):65-73.
    View in: PubMed
    Score: 0.002
  28. Atypical chronic lymphocytic leukemia with polyglandular autoimmune endocrinopathy type II: a complex profile. Leuk Lymphoma. 2014 Apr; 55(4):944-6.
    View in: PubMed
    Score: 0.002
  29. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components. Am J Hematol. 2013 Mar; 88(3):219-24.
    View in: PubMed
    Score: 0.002
  30. Acute lymphoblastic leukemia arising in post-polycythemic myelofibrosis: a rare entity. Leuk Lymphoma. 2012 Sep; 53(9):1839-41.
    View in: PubMed
    Score: 0.002
  31. CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. PLoS One. 2010 Dec 22; 5(12):e15183.
    View in: PubMed
    Score: 0.002
  32. The B cell antigen receptor in atypical chronic lymphocytic leukemia with t(14;19)(q32;q13) demonstrates remarkable stereotypy. Int J Cancer. 2011 Jun 01; 128(11):2759-64.
    View in: PubMed
    Score: 0.002
  33. Chronic lymphocytic leukemia With t(2;14)(p16;q32) involves the BCL11A and IgH genes and is associated with atypical morphologic features and unmutated IgVH genes. Am J Clin Pathol. 2009 May; 131(5):663-70.
    View in: PubMed
    Score: 0.002
  34. Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia. Blood. 2009 Jun 18; 113(25):6330-7.
    View in: PubMed
    Score: 0.002
  35. Immunophenotypic study of basophils by multiparameter flow cytometry. Arch Pathol Lab Med. 2008 May; 132(5):813-9.
    View in: PubMed
    Score: 0.002
  36. T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years. Leuk Res. 2007 Jul; 31(7):939-45.
    View in: PubMed
    Score: 0.001
  37. Transfusion therapy for patients with cancer. CA Cancer J Clin. 1985 Sep-Oct; 35(5):311-6.
    View in: PubMed
    Score: 0.001
  38. C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome. Leuk Res. 2004 Apr; 28(4):373-8.
    View in: PubMed
    Score: 0.001
  39. Evaluation of interphase fluorescence in situ hybridization for the t(14;18)(q32;q21) translocation in the diagnosis of follicular lymphoma on fine-needle aspirates: a comparison with flow cytometry immunophenotyping. Cancer. 2003 Dec 25; 99(6):385-93.
    View in: PubMed
    Score: 0.001
  40. Molecular differences between small and large cells in patients with chronic lymphocytic leukemia. Eur J Haematol. 2003 Oct; 71(4):235-42.
    View in: PubMed
    Score: 0.001
  41. Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes. Oncol Rep. 2003 Sep-Oct; 10(5):1513-8.
    View in: PubMed
    Score: 0.001
  42. Differences in CD33 intensity between various myeloid neoplasms. Am J Clin Pathol. 2002 Oct; 118(4):560-6.
    View in: PubMed
    Score: 0.001
  43. CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia. Leuk Res. 2002 Jul; 26(7):643-9.
    View in: PubMed
    Score: 0.001
  44. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease. Cancer. 2002 Mar 15; 94(6):1721-30.
    View in: PubMed
    Score: 0.001
  45. Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors. J Clin Apher. 2002; 17(1):7-16.
    View in: PubMed
    Score: 0.001
  46. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 2001 Sep 15; 98(6):1695-700.
    View in: PubMed
    Score: 0.001
  47. High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer. Cytotherapy. 2000; 2(2):105-10.
    View in: PubMed
    Score: 0.001
  48. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood. 1999 Aug 15; 94(4):1465-70.
    View in: PubMed
    Score: 0.001
  49. Successful treatment of progressive multifocal leukoencephalopathy with low-dose interleukin-2. Bone Marrow Transplant. 1997 Dec; 20(11):983-7.
    View in: PubMed
    Score: 0.001
  50. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. Leukemia. 1996 Sep; 10(9):1534-43.
    View in: PubMed
    Score: 0.001
  51. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients. Bone Marrow Transplant. 1995 Dec; 16(6):737-41.
    View in: PubMed
    Score: 0.001
  52. Analysis of CD7 expression in acute myelogenous leukemia: martingale residual plots combined with 'optimal' cutpoint analysis reveals absence of prognostic significance. Leukemia. 1995 Oct; 9(10):1735-41.
    View in: PubMed
    Score: 0.001
  53. Advances in the diagnosis of acute leukemia. Hematol Oncol Clin North Am. 1993 Feb; 7(1):1-46.
    View in: PubMed
    Score: 0.001
  54. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. J Clin Oncol. 1990 Jun; 8(6):994-1004.
    View in: PubMed
    Score: 0.000
  55. Positive immunohematologic and serologic test results due to high-dose intravenous immune globulin administration. Transfusion. 1987 Nov-Dec; 27(6):503.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.